Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | PHGDH | O43175 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14843166 | 1.00 | CYP1A2 (0.45) | CYP1A2TDP1HSD17B10CHRM1HTR1A | |
| Hydrochloric Acid SCHEMBL3402044 | 0.98 | CYP1A2 (0.43) | CYP1A2TDP1HSD17B10CHRM1HTR1A | |
| SCHEMBL14850782 | 0.89 | DPP7 (0.44) | DPP7DPP4 | |
| SCHEMBL14843027 | 0.89 | DPP7 (0.44) | DPP7DPP4 | |
| SCHEMBL30484009 | 0.84 | HTR1A (0.46) | CYP1A2TDP1HSD17B10CHRM1HTR1A | |
| SCHEMBL14843076 | 0.83 | DPP7 (0.41) | DPP7DPP4 | |
| SCHEMBL14843074 | 0.83 | DPP7 (0.41) | DPP7DPP4 | |
| SCHEMBL16435188 | 0.81 | DPP7 (0.46) | DPP7DPP4 | |
| SCHEMBL22917833 | 0.81 | CYP1A2 (0.42) | CYP1A2TDP1HSD17B10CHRM1HTR1A | |
| SCHEMBL15853672 | 0.81 | CYP1A2 (0.42) | CYP1A2TDP1HSD17B10CHRM1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2989095-B1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL PIPERAZIN-1 -YL)-3-OXO-PROPRYL]AMIDE | SANOFI SA (FR) | 2018-11-21 | — | — | EP | claimed |
| US-9637479-B2 | Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl-piperazin-1-yl)-3-oxo-propyl]amide | SANOFI (FR) | 2017-05-02 | — | — | US | claimed |
| US-20160102082-A1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL-PIPERAZIN-1-YL)-3-OXO-PROPYL]AMIDE | BEIJING COLLAB PHARM CO., LTD. (CN) | 2016-04-14 | — | — | US | claimed |
| EP-2989095-A1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL PIPERAZIN-1 -YL)-3-OXO-PROPRYL]AMIDE | SANOFI (FR) | 2016-03-02 | — | — | EP | claimed |
| WO-2014174102-A1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL PIPERAZIN-1 -YL)-3-OXO-PROPRYL]AMIDE | SANOFI (FR) | 2014-10-30 | — | — | WO | claimed |
| EP-2989095-B1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL PIPERAZIN-1 -YL)-3-OXO-PROPRYL]AMIDE | SANOFI SA (FR) | 2018-11-21 | — | — | EP | disclosed |
| US-9637479-B2 | Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl-piperazin-1-yl)-3-oxo-propyl]amide | SANOFI (FR) | 2017-05-02 | — | — | US | disclosed |
| US-20160102082-A1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL-PIPERAZIN-1-YL)-3-OXO-PROPYL]AMIDE | BEIJING COLLAB PHARM CO., LTD. (CN) | 2016-04-14 | — | — | US | disclosed |
| EP-2989095-A1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL PIPERAZIN-1 -YL)-3-OXO-PROPRYL]AMIDE | SANOFI (FR) | 2016-03-02 | — | — | EP | disclosed |
| WO-2014174102-A1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL PIPERAZIN-1 -YL)-3-OXO-PROPRYL]AMIDE | SANOFI (FR) | 2014-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160102082-A1 | TARTRATE SALT OF 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[METHYL-3-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYLAMINO]-3-(4-METHYL-PIPERAZIN-1-YL)-3-OXO-PROPYL]AMIDE | CPS1, ACP3, ACP1 | CYP1A2 3461/4885TDP1 531/4885HSD17B10 2298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.